Frequency of various cutaneous disorders in chronic hepatitis C virus infection

Journal of Pakistan Association of Dermatologists

Volumn 20, Issue 1, 2010, Pages 10-14

  Ejaz, Amer ^a   Ahmed, Riaz ^a   Fazal, Imran ^a   Tahir, Muhammad ^a  

^a Combined Military Hospital ^*  (Pakistan)

Author keywords

Chronic hepatitis C; Lichen planus; Skin manifestations; Urticaria; Vitiligo

Indexed keywords

ALPHA2B INTERFERON; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CRYOGLOBULIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RIBAVIRIN; SMOOTH MUSCLE ANTIBODY;

ADULT; ARTICLE; BLOOD CELL COUNT; CHRONIC URTICARIA; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; PURPURA; SIALOADENITIS; SKIN DISEASE; THROMBOCYTE COUNT; VASCULITIS; VITILIGO; XEROSTOMIA;

EID: 77953310905     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 2000; 75: 18-9.
2. Farooq MA, Iqbal MA, Tariq WZ et al. Prevalence of Hepatitis B and C in a healthy cohort. Pak J Pathol 2005; 16: 42-6.
3. Khokhar N, Gill ML, Malik GJ. General seroprevalence of Hepatitis C and Hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 534-6.
4. Amin J, Yousuf H, Mumtaz A et al. Prevalence of hepatitis B surface antigen and anti hepatitis C virus; Professional Med J 2004; 11: 334-7.
5. Shah NH, Shabbeir G. A Review of published literature on hepatitis B and C virus prevalence in Pakistan. J Coll Physicians Surg Pak 2002; 12: 368-71.
6. Bonkovsky HI, Mehta S. Hepatitis C: a review. J Am Acad Dermatol 2001; 44: 159-79.
7. Jackson JM. Hepatitis C and the skin. Dermatol Clin 2002; 20: 237-51.
8. Zakiullah M. Beware of hepatitis C - the silent epidemic. Med Today 2005; 3: 26-9.
9. Azfar NA, Zaman T, Rashid T, Jahangir M. Cutaneous manifestations of patients of hepatitis C. J Pak Assoc Dermatol 2008; 18: 138-48.
10. Umar M, Bushra HT, Shoaib A. Spectrum of chronic liver disease due to hepatitis C virus infection. J Coll Physicians Surg 2000; 10: 380-3.
11. Agnello V. Mixed cryoglobulinemia and other extrahepatic manifestations of HCV infection. In: Liang TJ, Hoofnagle JH, editors. Hepatitis C. New York: Academic Press; 2000: 295-15.
12. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol 1995; 22:316-23.
13. Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004; 40: 341-352.
14. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-70.
15. Sène D, Limal N, Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 2004; 19: 357-81.
16. Maticic M, Poljak M, Lunder T et al. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area. J Eur Acad Dermatol Venereol 2008; 22: 779-88.
17. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001; 59: 174-77.
18. Lodi G, Giuliani M, Majorana A et al. Lichen planus and hepatitis C virus: a multicenter study of patients with oral lesions and a systematic review. Br J Rheumatol 2004; 151: 1172-81.
19. Davis GL, Esteban-Mur R, Rustgi V et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339: 1493-9.
20. Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990; 336: 822-3.
21. Chia SC, Bergasa NV, Kleiner DE et al. Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci 1998; 43: 2177-83.
22. Haddad J, Deny P, Munz-Gotheil C. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339:321-3.